Roche and UCB Collaborate to Develop UCB0107 for Alzheimer’s Disease
Shots: UCB to receive $120M and is eligible to receive $2B as cost reimbursement, development, and commercial milestones as well as royalties on
[Read More...]
Collaborate
Ovid Therapeutics and University of Connecticut Collaborate to Accelerate the Development of OV101 (gaboxadol) for Angelman Syndrome
Shots: Ovid will collaborate with UConn’s Stormy J. Chamberlain and secures exclusive access to identified genetic sequences for shRNA-based therapy. Ovid plans to
[Read More...]
Chugai and Biofourmis Collaborate to Develop Solutions for Digitally Measuring Endometriosis Pain
Shots: The collaboration will deploy Biofourmis’ Biovitals platform to co-develop a novel digital technology for the objective assessment of pain using biosensors and
[Read More...]
Roche and Reverie Labs Collaborate to Advance Kinase Drug Discovery Programs
Shots: Reverie Labs to receive up front and is eligible to receive pre/clinical, regulatory milestones, as well as royalties on Roche’s sales of
[Read More...]
Dr. Reddy’s and GRA Collaborate with Fujifilm for Avigan (favipiravir) to Treat COVID-19 Outside Japan
Shots: Fujifilm to receive upfront, license fee along with royalties on sales of the therapy. Dr. Reddy’s and GRA to get the exclusive
[Read More...]
G1 Therapeutics and Boehringer Ingelheim Collaborate to Co-Promote Trilaciclib for Small Cell Lung Cancer in the US and Puerto Rico
Shots: Boehringer to receive payments to cover start-up expenses and pre-approval initiatives for a successful commercial launch. Additionally, it receives mid-twenties percentage of
[Read More...]
Takeda and Neurocrine Collaborate for Seven Neuro Programs Worth Up to $2B
Shots: Takeda to receive $120M as upfront in cash, ~ $495M as development milestones, and ~$1.4B as commercial milestones along with royalties on
[Read More...]
Intravacc and EpiVax Collaborate to Develop an Emerging Vaccine for COVID-19
Shots: Intravacc signs an agreement with EpiVax for the development of novel vaccine against COVID-19, based on Intravacc’s Outer Membrane Vesicles (OMV) technology
[Read More...]
Boehringer Ingelheim and Lilly Collaborate with DCRI for Evaluating Jardiance (empagliflozin) in a Pragmatic EMPACT-MI Study
Shots: The collaboration will evaluate whether Jardiance can improve outcomes and prevent heart failure in adults with/ out diabetes who had an acute
[Read More...]
Chi-Med and BeiGene Collaborate to Evaluate the Combinations of Surufatinib and Fruquintinib with Tislelizumab for Solid Tumors
Shots: The two companies collaborated to evaluate the safety, tolerability and efficacy of Chi-Med’s surufatinib and fruquintinib, with BeiGene’s tislelizumab against multiple solid
[Read More...]